Notify me when Chernett Jorey files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| AIRS | Airsculpt Technologies, Inc. | Common | 9.9% | $12,192,079 | +$5,876,726 | 6,156,061 | +93% | Chernett Jorey | 30 Jan 2026 |
| AEON | AEON Biopharma, Inc. | Common | 9.9% | $564,250 | 1,128,500 | Chernett Jorey | 27 May 2025 | ||
| KZIA | KAZIA THERAPEUTICS LTD | American Depositary Shares | 9.9% | 137,200 | Chernett Jorey | 11 Jun 2025 | |||
| Neuronetics, Inc. | Common | 9.9% | 6,827,031 | +55% | Chernett Jorey | 30 Jan 2026 | |||
| OKYO | OKYO Pharma Ltd | Common | 9.5% | $11,824,823 | +$2,541,903 | 3,802,194 | +27% | Chernett Jorey | 31 Dec 2025 |
| FEMY | FEMASYS INC | Common | 9.3% | $2,930,561 | +$1,361,799 | 3,034,335 | +87% | Chernett Jorey | 30 Jun 2025 |
| CALC | CalciMedica, Inc. | Common | 7.9% | $3,393,193 | 1,134,847 | Chernett Jorey | 24 Nov 2025 | ||
| TRAW | Traws Pharma, Inc. | Common | 6.8% | $668,220 | 543,268 | Chernett Jorey | 14 Jan 2026 | ||
| IOBT | IO Biotech, Inc. | Common | 6.3% | $2,317,201 | +$543,849 | 4,543,532 | +31% | Chernett Jorey | 31 Dec 2025 |
| XGN | EXAGEN INC. | Common | 5.4% | $7,487,143 | 1,231,438 | Chernett Jorey | 30 Jan 2026 | ||
| TLSA | Tiziana Life Sciences Ltd | Common | 5.4% | 6,476,471 | +8.8% | Chernett Jorey | 30 Sep 2025 | ||
| SMHI | SEACOR Marine Holdings Inc. | Common | 5.2% | $10,597,710 | +$1,498,706 | 1,409,270 | +16% | Chernett Jorey | 25 Dec 2025 |
| DFPH | Oncology Institute, Inc. | Common | 5.2% | 5,114,944 | Chernett Jorey | 14 Jan 2026 | |||
| LCTX | Lineage Cell Therapeutics, Inc. | Common | 5% | $13,848,454 | 11,445,003 | Chernett Jorey | 22 Sep 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|